About EARP and GARP complex-interacting protein 1
EARP and GARP complex-interacting protein 1 (EIPR1) is a protein
from Homo sapiens identified by UniProt accession
Q53HC9, 387 residues long.
MolForge cross-references it against 0 known binders and
56 disease associations.
Target properties
| Protein name | EARP and GARP complex-interacting protein 1 |
| UniProt accession | Q53HC9 |
| Gene | EIPR1 |
| Organism | Homo sapiens |
| Length | 387 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (56)
Diseases linked to this target (Open Targets).
- PHF-tau measurement · score 0.27
- cognitive decline measurement · score 0.24
- protein measurement · score 0.24
- Abnormality of refraction · score 0.15
- Lobular Breast Carcinoma In Situ · score 0.14
- insomnia measurement · score 0.14
- neuroticism measurement · score 0.12
- mental or behavioural disorder · score 0.11
- Blackfan-Diamond anemia · score 0.09
- primary familial polycythemia due to EPO receptor mutation · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q53HC9-F1 | alphafold | PREDICTED | 89.14 | — |
Amino-acid sequence (387 residues)
MEDDAPVIYG LEFQARALTP QTAETDAIRF LVGTQSLKYD NQIHIIDFDD ENNIINKNVL LHQAGEIWHI SASPADRGVL TTCYNRTSDS KVLTCAAVWR MPKELESGSH ESPDDSSSTA QTLELLCHLD NTAHGNMACV VWEPMGDGKK IISLADNHIL LWDLQESSSQ AVLASSASLE GKGQLKFTSG RWSPHHNCTQ VATANDTTLR GWDTRSMSQI YCIENAHGQL VRDLDFNPNK QYYLASCGDD CKVKFWDTRN VTEPVKTLEE HSHWVWNVRY NHSHDQLVLT GSSDSRVILS NMVSISSEPF GHLVDDDDIS DQEDHRSEEK SKEPLQDNVI ATYEEHEDSV YAVDWSSADP WLFASLSYDG RLVINRVPRA LKYHILL
Explore EARP and GARP complex-interacting protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets